PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1

Published:2019-06-19 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Guo Haihong,Treude Fabian,Krämer Oliver H.,Lüscher Bernhard,Hartkamp Jörg

Funder

Deutsche Forschungsgemeinschaft

START program of the Faculty of Medicine, RWTH Aachen University

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-45209-9.pdf

Reference45 articles.

1. Weir, H. K. et al. Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969–2020. Prev Chronic Dis 13, E157, https://doi.org/10.5888/pcd13.160211 (2016).

2. Martin-Sanchez, J. C. et al. Projections in Breast and Lung Cancer Mortality among Women: A Bayesian Analysis of 52 Countries Worldwide. Cancer Res 78, 4436–4442, https://doi.org/10.1158/0008-5472.CAN-18-0187 (2018).

3. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).

4. Slamon, D. J. et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177–182 (1987).

5. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752, https://doi.org/10.1038/35021093 (2000).

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress in the Use of Small Molecule Smac Mimetics in Combination Therapy of Cancer;Current Medicinal Chemistry;2024-05-20

2. Antitumor Efficacy of Arylquin 1 through Dose-Dependent Cytotoxicity, Apoptosis Induction, and Synergy with Radiotherapy in Glioblastoma Models;Biomedicines;2024-04-19

3. Evidence of direct interaction between cisplatin and the caspase‐cleaved prostate apoptosis response‐4 (cl‐Par‐4) tumor suppressor;Protein Science;2023-12-13

4. Anticancer genes (NOXA, PAR-4, TRAIL) are de-regulated in breast cancer patients and can be targeted by using a ribosomal inactivating plant protein (riproximin);Molecular Biology Reports;2023-05-01

5. Anticancer genes (NOXA, PAR-4, TRAIL) are de-regulated in breast cancer patients and can be targeted by using a ribosomal inactivating plant protein (riproximin);2023-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3